Masoumeh Navidinia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Masoumeh Navidinia has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Fatemeh Fallah
Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
8 shared publications - Abdollah Karimi
Pediatric Infections Research Center, Research Institute for Children's Health Shahid Beheshti University of Medical Sciences Tehran Iran
5 shared publications - Mehdi Goudarzi
Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 shared publications Mehdi Goudarzi
Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 shared publications- Bita Bakhshi
Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
3 shared publications Saadat Adabian
Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 shared publications
Latest Publications
- Open Access
- 12 April 2025
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 17 (2) , 293-302
Evaluation of the antagonistic effect of Pseudomonas aeruginosa toxins on azole antifungal resistance in Candida albicans species isolated from clinical samples in Iran
Background and Objectives: The azole antifungals are the most frequent class used to treat Candida infections. It is essential to elucidate the potential of natural compounds as an alternative in eliminating Candida albicans (C. albicans). Therefore, in the present study, the antagonistic effect of Pseudomonas aeruginosa toxins on azole antifungal resistance in C. albicans species was investigated. Materials and Methods: In this study, 28 C. albicans species with azole antifungal resistance were obtained from patients at Shohadaye Tajrish Hospital. The effect of toxins, such as phenazine, pyocyanin, pyoverdine, and fluorescein, was examined on C. albicans species. The antifungal activity of these toxins against C. albicans spp. was determined using methods such as minimal inhibitory concentration (MIC ), radial diffusion assay (RDA), and detection of reactive oxygen species (ROS). Results: The prevalence of C. albicans strains in urinary catheters, surgical wounds, respiratory tracts, blood, and standard strains was 46.3%, 21.4%, 25%, 7.14%, and 3.57%, respectively. The MIC values were reported as 32 µg/ml for phenazine, and 128 µg/ml for pyoverdine, pyocyanin, and fluorescein. The results showed that phenazine exhibited higher inhibitory effects against C. albicans isolated from clinical samples compared to the other toxins. After exposure to phenazines (20 µg/ ml), 65-70% of yeast cells of C. albicans spp. showed rhodamine 123 fluorescence, indicating high intracellular reactive oxygen species (ROS) production. Conclusion: The antifungal effect of different toxins in C. albicans spp. may be due to ROS-mediated apoptotic death. The results suggest that phenazine has high potential in controlling C. albicans. This natural compounds are a potential alternative for eliminating this yeast.
- 12 April 2025
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 17 (2) , 293-302
Open AccessEvaluation of the antagonistic effect of Pseudomonas aeruginosa toxins on azole antifungal resistance in Candida albicans species isolated from clinical samples in Iran
Background and Objectives: The azole antifungals are the most frequent class used to treat Candida infections. It is essential to elucidate the potential of natural compounds as an alternative in eliminating Candida albicans (C. albicans). Therefore, in the present study, the antagonistic effect of Pseudomonas aeruginosa toxins on azole antifungal resistance in C. albicans species was investigated. Materials and Methods: In this study, 28 C. albicans species with azole antifungal resistance were obtained from patients at Shohadaye Tajrish Hospital. The effect of toxins, such as phenazine, pyocyanin, pyoverdine, and fluorescein, was examined on C. albicans species. The antifungal activity of these toxins against C. albicans spp. was determined using methods such as minimal inhibitory concentration (MIC ), radial diffusion assay (RDA), and detection of reactive oxygen species (ROS). Results: The prevalence of C. albicans strains in urinary catheters, surgical wounds, respiratory tracts, blood, and standard strains was 46.3%, 21.4%, 25%, 7.14%, and 3.57%, respectively. The MIC values were reported as 32 µg/ml for phenazine, and 128 µg/ml for pyoverdine, pyocyanin, and fluorescein. The results showed that phenazine exhibited higher inhibitory effects against C. albicans isolated from clinical samples compared to the other toxins. After exposure to phenazines (20 µg/ ml), 65-70% of yeast cells of C. albicans spp. showed rhodamine 123 fluorescence, indicating high intracellular reactive oxygen species (ROS) production. Conclusion: The antifungal effect of different toxins in C. albicans spp. may be due to ROS-mediated apoptotic death. The results suggest that phenazine has high potential in controlling C. albicans. This natural compounds are a potential alternative for eliminating this yeast.
- Open Access
- 15 September 2024
- Published by Brieflands in Archives of Pediatric Infectious Diseases
- Vol. 12 (4)
Mini Review: Antimicrobial Agents Based on Natural Compounds: The Key to Solving the Current Crisis
Context: The rapid development of resistance mechanisms by bacteria has led to the loss of effectiveness of many commonly used antibiotics, posing a serious threat to global public health. Therefore, the objective of this study is to provide further insights into combating antibiotic resistance and addressing the urgent need for additional effective antimicrobial treatments as alternatives. Methods: In this narrative review, natural compounds derived from plants, fungi, and other sources were evaluated for their antimicrobial properties based on clinical trials and in vitro studies. These compounds have gained attention due to their potential to serve as alternative or adjunctive therapies. Results: We briefly reviewed and introduced antibacterial agents derived from natural substances and extracts as an alternative solution to the current crisis. Many natural sources, such as antimicrobial peptides (AMPs), nanoparticles, enzyme disruption of acylhomoserine lactones (AHLs), Mur enzymes, lysocine E, plant-derived natural products, polyphenols, nanozymes, antimicrobial peptidomimetics, and antimicrobials of fungal origin (such as penicillin, griseofulvin, amphotericin B, echinocandins, and statins), produce a wide range of secondary metabolites with the potential to exhibit antibacterial activity. Moreover, natural products often possess complex chemical structures, which can target multiple bacterial pathways, enhancing their ability to inhibit or kill bacteria. Conclusions: This study contributes new knowledge and perspectives on combating antibiotic resistance by exploring alternative treatments and natural products, which represent an important area of research. It may offer new solutions to address the urgent need for effective antimicrobial treatments. Further research is necessary to isolate, identify, and characterize the active compounds, study their mechanisms of action, optimize their efficacy and safety, and evaluate their potential for clinical use.
- 15 September 2024
- Published by Brieflands in Archives of Pediatric Infectious Diseases
- Vol. 12 (4)
Open AccessMini Review: Antimicrobial Agents Based on Natural Compounds: The Key to Solving the Current Crisis
Context: The rapid development of resistance mechanisms by bacteria has led to the loss of effectiveness of many commonly used antibiotics, posing a serious threat to global public health. Therefore, the objective of this study is to provide further insights into combating antibiotic resistance and addressing the urgent need for additional effective antimicrobial treatments as alternatives. Methods: In this narrative review, natural compounds derived from plants, fungi, and other sources were evaluated for their antimicrobial properties based on clinical trials and in vitro studies. These compounds have gained attention due to their potential to serve as alternative or adjunctive therapies. Results: We briefly reviewed and introduced antibacterial agents derived from natural substances and extracts as an alternative solution to the current crisis. Many natural sources, such as antimicrobial peptides (AMPs), nanoparticles, enzyme disruption of acylhomoserine lactones (AHLs), Mur enzymes, lysocine E, plant-derived natural products, polyphenols, nanozymes, antimicrobial peptidomimetics, and antimicrobials of fungal origin (such as penicillin, griseofulvin, amphotericin B, echinocandins, and statins), produce a wide range of secondary metabolites with the potential to exhibit antibacterial activity. Moreover, natural products often possess complex chemical structures, which can target multiple bacterial pathways, enhancing their ability to inhibit or kill bacteria. Conclusions: This study contributes new knowledge and perspectives on combating antibiotic resistance by exploring alternative treatments and natural products, which represent an important area of research. It may offer new solutions to address the urgent need for effective antimicrobial treatments. Further research is necessary to isolate, identify, and characterize the active compounds, study their mechanisms of action, optimize their efficacy and safety, and evaluate their potential for clinical use.
- Open Access
- 19 August 2024
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 19 (4)
A Narrative Review; Relation of Coronavirus Disease 2019 (COVID-19) with Several Hematological Disorders
Context: It's crucial to monitor hematologic biomarkers in patients with coronavirus disease 2019 (COVID-19) to identify abnormalities and guide treatment decisions. These biomarkers provide valuable information about the severity of the disease and assist healthcare providers in making informed decisions about patient care. Evidence Acquisition: The present study reviewed the most recent literature on hematologic biomarker abnormalities in patients with COVID-19 and considered their clinical significance. Results: Various abnormalities were observed in hematologic biomarkers, including prothrombin time (PT), partial thromboplastin time (PTT), red blood cell indices, interferon regulatory factor (IRF-7), and white blood cell (WBC) count. Notably, significant lymphocytopenia, thrombocytopenia, and leukocytosis were reported in patients with severe and fatal COVID-19 compared to those with non-severe disease and survivors. Conclusions: Hematologic biomarkers play a crucial role in understanding COVID-19 pathogenesis and guiding clinical management. Utilizing these markers allows clinicians to assess disease severity, predict prognosis, and tailor treatment strategies to improve patient outcomes. Continued research in this area is essential to fully realize the potential of hematologic biomarkers for COVID-19 management.
- 19 August 2024
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 19 (4)
Open AccessA Narrative Review; Relation of Coronavirus Disease 2019 (COVID-19) with Several Hematological Disorders
Context: It's crucial to monitor hematologic biomarkers in patients with coronavirus disease 2019 (COVID-19) to identify abnormalities and guide treatment decisions. These biomarkers provide valuable information about the severity of the disease and assist healthcare providers in making informed decisions about patient care. Evidence Acquisition: The present study reviewed the most recent literature on hematologic biomarker abnormalities in patients with COVID-19 and considered their clinical significance. Results: Various abnormalities were observed in hematologic biomarkers, including prothrombin time (PT), partial thromboplastin time (PTT), red blood cell indices, interferon regulatory factor (IRF-7), and white blood cell (WBC) count. Notably, significant lymphocytopenia, thrombocytopenia, and leukocytosis were reported in patients with severe and fatal COVID-19 compared to those with non-severe disease and survivors. Conclusions: Hematologic biomarkers play a crucial role in understanding COVID-19 pathogenesis and guiding clinical management. Utilizing these markers allows clinicians to assess disease severity, predict prognosis, and tailor treatment strategies to improve patient outcomes. Continued research in this area is essential to fully realize the potential of hematologic biomarkers for COVID-19 management.
- Open Access
- 13 February 2023
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 15 (1) , 1-9
The clinical outcomes of gut-brain axis (GBA) microbiota influence on psychiatric disorders
The gut microbiome plays an important role in the health of the body. The study of its effect on mental problems has become the main topic of this study. As a matter of fact, every change in the gut microbiota composition can influence on mood and anxiety and vice versa. So, considering this “microbiota-gut-brain” axis (GBA) is so important. In this narrative review, the most recent reproduced information on GBA roles in neuropsychiatric disorders, and clinical significance have been consid- ered. The gut microbial population is formed from birth and transforms from an immature state to the postnatal period into a more intricate and diverse adult ecosystem. In this review, we had some findings that GBA implicated in some psychiatric problems which can be a dysregulation consequence. In addition, some bacteria have been implicated in causing mental disorders in humans such as depression, obsessive-compulsive disorder, psychiatric disorders, stress disorders, schizophrenia and, autism. The absence of balance in GBA natural state can cause several negative consequences on host health which leads to neurological problems. Possibly, findings were delineating an interesting new etiological pathway for future exploration.
- 13 February 2023
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 15 (1) , 1-9
Open AccessThe clinical outcomes of gut-brain axis (GBA) microbiota influence on psychiatric disorders
The gut microbiome plays an important role in the health of the body. The study of its effect on mental problems has become the main topic of this study. As a matter of fact, every change in the gut microbiota composition can influence on mood and anxiety and vice versa. So, considering this “microbiota-gut-brain” axis (GBA) is so important. In this narrative review, the most recent reproduced information on GBA roles in neuropsychiatric disorders, and clinical significance have been consid- ered. The gut microbial population is formed from birth and transforms from an immature state to the postnatal period into a more intricate and diverse adult ecosystem. In this review, we had some findings that GBA implicated in some psychiatric problems which can be a dysregulation consequence. In addition, some bacteria have been implicated in causing mental disorders in humans such as depression, obsessive-compulsive disorder, psychiatric disorders, stress disorders, schizophrenia and, autism. The absence of balance in GBA natural state can cause several negative consequences on host health which leads to neurological problems. Possibly, findings were delineating an interesting new etiological pathway for future exploration.
- Open Access
- 2 October 2021
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 16 (3)
Biofilm Matrix Formation in Human: Clinical Significance, Diagnostic Techniques, and Therapeutic Drugs
Context: Some recent reports have indicated that almost 80% of clinical infections in humans have biofilm origin and impose additional healthcare costs. This study was an updated review of extracellular polymeric substance matrix (biofilm) formation in humans and elaborated on its clinical significance, diagnosis, and therapeutic approaches. Evidence Acquisition: This narrative study reviewed the most recent information on the significance of microbial biofilm formation in clinical settings, common biofilm-producing bacterial species, its diagnosis, antibiotic drug resistance, and new approaches to the treatment of infections associated with biofilm formation. Results: Evidence indicated a permanent increase in the frequency of microbial biofilm in the central venous catheter, mechanical heart valve, and urinary catheter, as well as persistent infections. However, antimicrobial resistance induced by biofilms formation and the antimicrobial treatment of biofilms were problematic. Moreover, several assays and lab devices were described to evaluate biofilm formation. Furthermore, new attitudes towards anti-biofilm treatments were introduced in this paper. Conclusions: The number of different mechanisms were in accordance with the recent knowledge on how biofilms play a critical role in the disease pathogenesis. Biofilm strikes the treatment and surveillance of patients bearing infectious diseases under different conditions. The use of new methods in anti-biofilm treatments is effective for the recovery of infected patients.
- 2 October 2021
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 16 (3)
Open AccessBiofilm Matrix Formation in Human: Clinical Significance, Diagnostic Techniques, and Therapeutic Drugs
Context: Some recent reports have indicated that almost 80% of clinical infections in humans have biofilm origin and impose additional healthcare costs. This study was an updated review of extracellular polymeric substance matrix (biofilm) formation in humans and elaborated on its clinical significance, diagnosis, and therapeutic approaches. Evidence Acquisition: This narrative study reviewed the most recent information on the significance of microbial biofilm formation in clinical settings, common biofilm-producing bacterial species, its diagnosis, antibiotic drug resistance, and new approaches to the treatment of infections associated with biofilm formation. Results: Evidence indicated a permanent increase in the frequency of microbial biofilm in the central venous catheter, mechanical heart valve, and urinary catheter, as well as persistent infections. However, antimicrobial resistance induced by biofilms formation and the antimicrobial treatment of biofilms were problematic. Moreover, several assays and lab devices were described to evaluate biofilm formation. Furthermore, new attitudes towards anti-biofilm treatments were introduced in this paper. Conclusions: The number of different mechanisms were in accordance with the recent knowledge on how biofilms play a critical role in the disease pathogenesis. Biofilm strikes the treatment and surveillance of patients bearing infectious diseases under different conditions. The use of new methods in anti-biofilm treatments is effective for the recovery of infected patients.
- Open Access
- 23 February 2020
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 15 (1)
Antibiofilm Activity of Cellobiose Dehydrogenase Enzyme (CDH) Isolated from Aspergillus niger on Biofilm of Clinical Staphylococcus epidermidis and Pseudomonas aeruginosa Isolates
It is estimated that more than 80% of cases of human infections are related to biofilm formation by invasive bacteria. So, in this study, we considered the ...
- 23 February 2020
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 15 (1)
Open AccessAntibiofilm Activity of Cellobiose Dehydrogenase Enzyme (CDH) Isolated from Aspergillus niger on Biofilm of Clinical Staphylococcus epidermidis and Pseudomonas aeruginosa Isolates
It is estimated that more than 80% of cases of human infections are related to biofilm formation by invasive bacteria. So, in this study, we considered the ...
- 1 April 2019
- Published by Allerton Press in Molecular Genetics, Microbiology and Virology
- Vol. 34 (2) , 124-130
Diversity of Prophages, spa, and SCCmec Types in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Burn Patients: A Study in a Referral Burn Hospital in Tehran, Iran
Infections with multidrug resistance methicillin-resistant Staphylococcus aureusin burn patients are one of the main dilemmas in public health. The aim of this study was to investigate the...
- 1 April 2019
- Published by Allerton Press in Molecular Genetics, Microbiology and Virology
- Vol. 34 (2) , 124-130
Diversity of Prophages, spa, and SCCmec Types in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Burn Patients: A Study in a Referral Burn Hospital in Tehran, Iran
Infections with multidrug resistance methicillin-resistant Staphylococcus aureusin burn patients are one of the main dilemmas in public health. The aim of this study was to investigate the...
- Open Access
- 12 March 2019
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. In Press (In Press)
Overview Perspective of Bacterial Strategies of Resistance to Biocides and Antibiotics
Considerable controversy surrounds the use of biocides in an ever-growing range of consumer products and the eventuality that their indiscriminate consumption might decrease biocide effectiveness and modify susceptibilities to antibiotics. Several line of evidence suggest that exposure to biocides may cause increased antibiotic resistance. Thus, we reviewed the common resistance strategies of bacteria against both biocides and antibiotics.Several publications have explained the cell target of biocides and the various mechanisms used by bacterial cells to escape biocides’ toxic activity. Here, we briefly reviewed the commonly used resistance mechanisms of bacteria against both biocides and antibiotics.Biocides could act on multiple sites in microorganisms and cause resistance by non-specific means. We mentioned several mechanisms such as efflux pumps, cell wall changes to the reduction of permeability, genetic linkage with both biocide resistance genes and antibiotic resistance genes, the penetration/uptake changes in envelope by passive diffusion, effect on the integrity and morphology of membrane, and effects on diverse key steps of bacterial metabolism. Along with this toxic effect and stress, bacterial cells express some similar defense strategies that can overlap the main functions conferring resistance versus structurally non-related molecules.It can be stated that healthcare-associated, community-acquired, and nosocomial infections should be surveyed annually. Since biocide-antibiotic cross-resistance can be conferred by a number of distinct mechanisms, it is important to evaluate the propensity of a bacterium to express these mechanisms. Advances in modern genetic methods and the development of an assay using specific chemosensitizers or markers might allow the development of routine tests to identify resistance mechanisms. Further studies are needed to establish a correlation between biocide exposure (s) and development of antibiotic resistance, but the number of studies in the clinical or environmental settings is limited.
- 12 March 2019
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. In Press (In Press)
Open AccessOverview Perspective of Bacterial Strategies of Resistance to Biocides and Antibiotics
Considerable controversy surrounds the use of biocides in an ever-growing range of consumer products and the eventuality that their indiscriminate consumption might decrease biocide effectiveness and modify susceptibilities to antibiotics. Several line of evidence suggest that exposure to biocides may cause increased antibiotic resistance. Thus, we reviewed the common resistance strategies of bacteria against both biocides and antibiotics.Several publications have explained the cell target of biocides and the various mechanisms used by bacterial cells to escape biocides’ toxic activity. Here, we briefly reviewed the commonly used resistance mechanisms of bacteria against both biocides and antibiotics.Biocides could act on multiple sites in microorganisms and cause resistance by non-specific means. We mentioned several mechanisms such as efflux pumps, cell wall changes to the reduction of permeability, genetic linkage with both biocide resistance genes and antibiotic resistance genes, the penetration/uptake changes in envelope by passive diffusion, effect on the integrity and morphology of membrane, and effects on diverse key steps of bacterial metabolism. Along with this toxic effect and stress, bacterial cells express some similar defense strategies that can overlap the main functions conferring resistance versus structurally non-related molecules.It can be stated that healthcare-associated, community-acquired, and nosocomial infections should be surveyed annually. Since biocide-antibiotic cross-resistance can be conferred by a number of distinct mechanisms, it is important to evaluate the propensity of a bacterium to express these mechanisms. Advances in modern genetic methods and the development of an assay using specific chemosensitizers or markers might allow the development of routine tests to identify resistance mechanisms. Further studies are needed to establish a correlation between biocide exposure (s) and development of antibiotic resistance, but the number of studies in the clinical or environmental settings is limited.
- Open Access
- 18 February 2019
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. In Press (In Press)
Molecular Analysis and Integron Carriage of Mupirocin-Resistant Staphylococcus aureus Strains Isolated from Burn Wound Infections, Tehran, Iran
The prevalence of wound infections associated with multidrug-resistant Staphylococcus aureus (S. aureus) strains among burns patients has tremendously increased. Recently, the role of integrons as a key system involved in spreading multi-drug resistance has been well documented.To investigate the prevalence of integrons, antimicrobial resistance pattern, and S. aureus protein A (spa) typing of the mupirocin-resistant S. aureus (MRSA) strains obtained from a referral burns hospital in Tehran, Iran.This study was performed during January 2017 to April 2018 on 64 MRSA isolates gathered from burns patients. The isolates were examined for susceptibility to antimicrobial agents. The integrase-encoding gene was detected by conventional polymerase chain reaction (PCR). Integrase-positive strains were evaluated for the determination of integron classes by using PCR-restriction fragment length polymorphism assay, and genotyping was performed by spa typing.Out of 64 MRSA strains, 24 (37.5%) and 40 (62.5%) isolates carried high-level and low-level resistance, respectively. The findings revealed that the entire isolates were MRSA. They belonged to six different spa types including t860 (40.6%), t790 (21.8%), t037 (17.2%), t064 (17.2%), t008 (1.6%), and t631 (1.6%). Class 1 and 2 integrons were found in 59.4% and 17.2% of the isolates, respectively, and 4 (6.2%) isolates were observed to carry class 1 and 2 integrons simultaneously.Precise epidemiological monitoring of integrons is required to prevent mupirocin resistance dissemination in MRSA strains.
- 18 February 2019
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. In Press (In Press)
Open AccessMolecular Analysis and Integron Carriage of Mupirocin-Resistant Staphylococcus aureus Strains Isolated from Burn Wound Infections, Tehran, Iran
The prevalence of wound infections associated with multidrug-resistant Staphylococcus aureus (S. aureus) strains among burns patients has tremendously increased. Recently, the role of integrons as a key system involved in spreading multi-drug resistance has been well documented.To investigate the prevalence of integrons, antimicrobial resistance pattern, and S. aureus protein A (spa) typing of the mupirocin-resistant S. aureus (MRSA) strains obtained from a referral burns hospital in Tehran, Iran.This study was performed during January 2017 to April 2018 on 64 MRSA isolates gathered from burns patients. The isolates were examined for susceptibility to antimicrobial agents. The integrase-encoding gene was detected by conventional polymerase chain reaction (PCR). Integrase-positive strains were evaluated for the determination of integron classes by using PCR-restriction fragment length polymorphism assay, and genotyping was performed by spa typing.Out of 64 MRSA strains, 24 (37.5%) and 40 (62.5%) isolates carried high-level and low-level resistance, respectively. The findings revealed that the entire isolates were MRSA. They belonged to six different spa types including t860 (40.6%), t790 (21.8%), t037 (17.2%), t064 (17.2%), t008 (1.6%), and t631 (1.6%). Class 1 and 2 integrons were found in 59.4% and 17.2% of the isolates, respectively, and 4 (6.2%) isolates were observed to carry class 1 and 2 integrons simultaneously.Precise epidemiological monitoring of integrons is required to prevent mupirocin resistance dissemination in MRSA strains.
- Open Access
- 31 March 2017
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 11 (1) , 111-117
Capsular Genotypes Distribution and Antibiotic Resistance pattern of Group B Streptococcus (GBS) Isolated from Clinical Samples, Tehran, Iran
- 31 March 2017
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 11 (1) , 111-117
Open AccessCapsular Genotypes Distribution and Antibiotic Resistance pattern of Group B Streptococcus (GBS) Isolated from Clinical Samples, Tehran, Iran